Study of Ketamine as an Antidepressant in Major Depressive Disorder
NCT01573741
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Ketamine
Sponsor
Shi Jinyun